Literature DB >> 26297838

Troxis necrosis, a novel mechanism for drug-induced hepatitis secondary to immunomodulatory therapy.

Christina H Wei1, Andrew Penunuri1, George Karpouzas2, Wayne Fleishman1, Anuj Datta2, Samuel W French1.   

Abstract

OBJECTIVES: A case of drug-induced hepatitis mediated by troxis necrosis, a form of autoimmune hepatitis, is described.
METHODS: Clinical data, light and electron microscopy of an ultrasound-guided core needle liver biopsy specimen, were examined to investigate the cause of transaminitis in a 26year old male patient on Cellcept and Plaquenil for the treatment of lupus erythematosus. A systematic PUBMED review of troxis necrosis as the underlying mechanism for drug-induced hepatitis was performed.
RESULTS: Liver function tests (LFTs) were significant for elevated AST (305) and ALT (174); the autoimmune workup was significant for anti-ANA positivity and α-SMA negativity. On light microscopy, the liver biopsy shows focal areas of lymphocytic infiltrates surrounding and forming immunologic synapses with lobular hepatocytes, indicating lobular hepatitis of autoimmune nature. Electron microscopy confirmed the presence of immunologic synapses. Upon cessation of the offending medications, the LFTs returned to baseline with no further intervention. Literature search yielded 7 previously reported cases of drug-induced hepatitis mediated by troxis necrosis.
CONCLUSION: Troxis necrosis is a novel mechanism for drug-induced hepatitis, including immunomodulatory medications including a monoclonal anti-TWEAK antibody and Cellcept and Plaquenil, two widely used immunosuppression/anti-rejection medications.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drug induced hepatitis; Immunologic synapse; Troxis necrosis

Mesh:

Substances:

Year:  2015        PMID: 26297838      PMCID: PMC4593393          DOI: 10.1016/j.yexmp.2015.08.006

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  16 in total

1.  "Piecemeal" necrosis: renamed troxis necrosis.

Authors:  M X Wang; T Morgan; W Lungo; L Wang; G Z Sze; S W French
Journal:  Exp Mol Pathol       Date:  2001-10       Impact factor: 3.362

Review 2.  Basic science for the clinician 30: The immunologic synapse.

Authors:  Leonard H Sigal
Journal:  J Clin Rheumatol       Date:  2005-08       Impact factor: 3.517

Review 3.  The TWEAK-Fn14 system as a potential drug target.

Authors:  Harald Wajant
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

4.  Costimulation: building an immunological synapse.

Authors:  M L Dustin; A S Shaw
Journal:  Science       Date:  1999-01-29       Impact factor: 47.728

Review 5.  Piecemeal necrosis of the liver revisited a review.

Authors:  S W French; E T Enbom
Journal:  Exp Mol Pathol       Date:  2014-04-01       Impact factor: 3.362

6.  A phase I monotherapy study of RG7212, a first-in-class monoclonal antibody targeting TWEAK signaling in patients with advanced cancers.

Authors:  Ulrik N Lassen; Didier Meulendijks; Lilian L Siu; Vaios Karanikas; Morten Mau-Sorensen; Jan H M Schellens; Derek J Jonker; Aaron R Hansen; Mary E Simcox; Kathleen J Schostack; Dean Bottino; Hua Zhong; Markus Roessler; Suzana M Vega-Harring; Tiantom Jarutat; David Geho; Ka Wang; Mark DeMario; Glenwood D Goss
Journal:  Clin Cancer Res       Date:  2014-11-11       Impact factor: 12.531

7.  Hepatic overexpression of MHC class II antigens and macrophage-associated antigens (CD68) in patients with biliary atresia of poor prognosis.

Authors:  H Kobayashi; P Puri; D S O'Briain; R Surana; T Miyano
Journal:  J Pediatr Surg       Date:  1997-04       Impact factor: 2.545

Review 8.  Mycophenolate mofetil: An update.

Authors:  Maria Cristina Villarroel; Manuel Hidalgo; Antonio Jimeno
Journal:  Drugs Today (Barc)       Date:  2009-07       Impact factor: 2.245

9.  CD28 plays a critical role in the segregation of PKC theta within the immunologic synapse.

Authors:  Jianyong Huang; Pei-Fen Lo; Tomasz Zal; Nicholas R J Gascoigne; Brian A Smith; Steven D Levin; Howard M Grey
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-20       Impact factor: 11.205

10.  Hepatitis due to mycophenolate mofetil used to treat atopic dermatitis and allergic contact dermatitis.

Authors:  Roselynn H Nguyen; Ponciano D Cruz
Journal:  Dermatitis       Date:  2014 Sep-Oct       Impact factor: 4.845

View more
  2 in total

1.  Case Report: Hepatotoxicity Associated with the Use of Hydroxychloroquine in a Patient with COVID-19.

Authors:  Melissa Barreto Falcão; Luciano Pamplona de Góes Cavalcanti; Nivaldo Menezes Filgueiras Filho; Carlos Alexandre Antunes de Brito
Journal:  Am J Trop Med Hyg       Date:  2020-06       Impact factor: 2.345

Review 2.  Mechanisms and consequences of COVID-19 associated liver injury: What can we affirm?

Authors:  Carlos Antunes Brito; Fabio Marinho Barros; Edmundo Pessoa Lopes
Journal:  World J Hepatol       Date:  2020-08-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.